A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease

Grant

Date/time Interval

  • November 22, 2013 - November 21, 2020
  • Awarded By

    Total Award Amount

  • 1445900.00
  • Direct Costs

  • 1147541.00
  • Sponsor Award Id

  • Contributor

  • Aparna Singhal   Investigator  
  • Bryan Smelser   Investigator  
  • David Geldmacher   Investigator  
  • Erik Roberson   Principal Investigator  
  • Khurram Bashir   Investigator  
  • Louis Nabors M.D.   Investigator  
  • Marissa Natelson Love   Investigator  
  • Philip Chapman   Investigator  
  • Roberta May   Investigator  
  • Tiffany Mayo   Investigator